Can You Advertise Foundayo and the Wegovy Pill? Ad Rules for GLP-1 Pills on Meta, Google, TikTok and Microsoft

Google: certification for the prescriber and the keyword

Google says advertisers must be certified to serve ads for prescription drug services, telemedicine providers included. In the United States it allows telemedicine providers accredited by LegitScript's Healthcare Merchant Certification Program, who must also be certified with Google. Its Restricted drug terms policy lets US campaigns name prescription drugs in ads and landing pages without certification, but requires certification to keyword-target them, and for telemedicine providers regardless.

Google's October 2026 update to its business name rules adds one more line: third-party resellers, affiliate distributors and secondary sellers may not use the standalone brand name of the goods they offer as their business name. The business name on the ad is the brand's own, never the drug's. Google's Misrepresentation policy also bans making it seem you're supported by another brand when you're not. Trademark questions are covered in our answer on naming Ozempic, Wegovy and Zepbound in ads.

Microsoft: preapproval and weight loss limits

Microsoft Advertising's Healthcare and Pharmaceutical policy, last updated October 5, 2026, says online pharmacies and telemedicine providers that sell prescription drugs must be preapproved before their ads serve, and the United States is one of the allowed markets. All health ads must target people 18 and over, and ads that promote prescription drugs must keep claims consistent with the product's indications, directions and warnings.

Its weight loss section is stricter than Meta's on numbers. Ads must not reference specific rates or amounts of weight loss, must not suggest results are guaranteed or permanent, and must encourage users to consult a healthcare professional before beginning any intensive program. An average percentage of body weight lost, lifted from a trial press release, fails there. The rest is in our answer on GLP-1 on Microsoft Ads.

TikTok: approval is necessary, not sufficient

TikTok's Healthcare and Pharmaceuticals policy, last updated September 2026, says prescription medicine may be allowed in the United States if the advertiser provides proof of approval and certification from regulators such as the FDA, with ads restricted to people 18 or older. Foundayo and the Wegovy pill have FDA approval, which a compounded GLP-1 can never show. The US section has no line for telehealth prescribers, so ask TikTok in writing whether you qualify.

TikTok's Weight Management policy applies either way. Weight loss claims must be restricted to people 18 or older and made through the promotion of a healthy lifestyle, and ads can't claim a product alone, without diet or exercise, leads to weight loss. That matches the approved use FDA lists for Foundayo, alongside diet and physical activity. More in our answer on GLP-1 on TikTok.

Claims that still fail after approval

• Trial numbers as promises. A mean weight loss figure shown as what the viewer will lose is an outcome claim on Meta and a banned specific amount on Microsoft. The FTC expects health claims to rest on competent and reliable scientific evidence.
• Pill and compounded side by side. FDA warns telehealth companies against describing a compounded drug as the same as an FDA-approved one, so a compounded offer can't borrow the pill's name or results.
• A price before authorization. Meta lists the price of a prescription drug among what authorized advertisers can show, so an ad that prices Foundayo waits for authorization.

What MedScale does

MedScale Health checks the brand's LegitScript status, files Meta authorization, Google certification and Microsoft preapproval in the brand's own accounts, and runs service ads while they are pending. Pill ads sit in their own ad sets, apart from any compounded offer, and every ad and landing page is checked before it ships. Start with a growth audit at medscale.health/audit.